CVS Health Corp. buy Mizuho
Summary
This prediction ended on 25.10.25 with a price of €70.93. With a performance of 35.23% the BUY prediction by Mizuho was a big success. Mizuho has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €0.64 are taken into consideration when calculating the performance. Mizuho has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -2.213% | -2.213% | 6.592% |
| iShares Core DAX® | 0,05 % | 1,31 % | 11,38 % |
| iShares Nasdaq 100 | 1,60 % | -0,90 % | 7,29 % |
| iShares Nikkei 225® | 3,06 % | 12,95 % | 33,77 % |
| iShares S&P 500 | 0,82 % | 0,70 % | 4,93 % |
Comments by Mizuho for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.